1 / 37

management of acute stroke

Case. This 62 yo male presents to the ER with acute right hemiparesis and aphasia. PMH: CABG 3 years ago, HTN, hyperlipidemia, and BPH.Medications: ASA 81mg, Lisinopril 20mg, Pravastatin 40mg, saw palmetto.PE: 182/94, 86 regular, AF. 2/5 right hemiparesis with nonfluent aphasia.What do you want to do first?.

Antony
Télécharger la présentation

management of acute stroke

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


    1. Management of acute stroke Eric Kraus, MD Neurology

    2. Case

    3. Initial work-up Document time of onset Consider t-PA NIHSS (stroke scale) EKG Noncontrast head CT Labs

    4. Initial work-up Time of onset Consider t-PA NIHSS (stroke scale) EKG Noncontrast head CT Labs < 3 hours ..and meet inclusion and exclusion criteria Intra-venous t-PA 3-6 hours ..and have a large artery occlusion (ICA, MCA, ACA, PCA, vertebral, basilar) CT angiogram Intra-arterial t-PA > 6 hours ..and basilar occlusion which is largely fatal if not opened CT angiogram Intra-arterial t-PA

    5. t-PA: Inclusion Age 18-80 Ischemic stroke NIHSS > 4 Onset < 3 hours ASA use okay

    6. t-PA: Exclusion Hemorrhagic stroke NIHSS > 20 (caution) Rapidly improving symptoms Hx stroke w/in 6 weeks Possible seizure cause of paralysis Previous known intracranial hemorrhage, tumor, AVM, aneurysm Presumed septic embolus Recent MI Trauma with internal injury w/in 30d Recent head trauma w/in 90d SBP > 185, DBP > 110 Glucose < 50 or > 400 Plts < 100K Hct < 25 Hereditary or acquired (Coumadin) bleeding disorder, INR > 1.7 Recent internal bleeding Recent surgery Pregnancy or parturition w/in 30d Arterial or venous puncture at noncompressible sites w/in 1wk Other serious/terminal illness

    7. NINDS t-PA trial Good outcome No or minimal disability at 3 months 29% placebo 41% t-PA Bleeding risk 0.6% placebo 6.4% t-PA

    8. CT Angiogram Contraindications Contrast allergy Cr > 1.5 Alternatives MRA Limited catheter angiogram

    9. Initial work-up Time of onset Consider t-PA NIHSS (stroke scale) Min score = 0 Max score = 42 Must be > 4 Caution > 20 EKG Noncontrast head CT Labs Assessment of: Level of consciousness Gaze Visual fields Facial weakness Arm and leg weakness Limb ataxia Sensation Best language Dysarthria Inattention or neglect

    10. Initial work-up Time of onset Consider t-PA NIHSS (stroke scale) EKG Noncontrast head CT Labs Ischemic changes A-fib

    11. Initial work-up Time of onset Consider t-PA NIHSS (stroke scale) EKG Noncontrast head CT Labs

    12. Initial work-up Time of onset Consider t-PA NIHSS (stroke scale) EKG Noncontrast head CT Labs

    13. Initial work-up Time of onset Consider t-PA NIHSS (stroke scale) EKG Noncontrast head CT Labs

    14. Initial work-up Time of onset Consider t-PA NIHSS (stroke scale) EKG Noncontrast head CT Labs

    15. Initial work-up Time of onset Consider t-PA NIHSS (stroke scale) EKG Noncontrast head CT Labs

    16. Initial work-up Time of onset Consider t-PA NIHSS (stroke scale) EKG Noncontrast head CT Labs

    17. Initial work-up Time of onset Consider t-PA NIHSS (stroke scale) EKG Noncontrast head CT Labs

    18. Initial work-up Time of onset Consider t-PA NIHSS (stroke scale) EKG Noncontrast head CT Labs

    19. Initial work-up Time of onset Consider t-PA NIHSS (stroke scale) EKG Noncontrast head CT Labs Hemorrhage CT angiogram ..and on antiplatelet drug Consider 6-pack plts ..and on Coumadin Vit K 10mg IV 4 units FFP repeated until INR <= 1.5 ..and on heparin Protamine 25mg IV, repeat 10mg IV prn

    20. Initial work-up Time of onset Consider t-PA NIHSS (stroke scale) EKG Noncontrast head CT Labs Hemorrhage causes HTN Amyloid angiopathy Trauma Bleeding predisposition Hereditary Acquired Vascular malformation Aneurysm

    21. Initial work-up Time of onset Consider t-PA NIHSS (stroke scale) EKG Noncontrast head CT Labs

    22. Initial work-up Time of onset Consider t-PA NIHSS (stroke scale) EKG Noncontrast head CT Labs

    23. Initial work-up Time of onset Consider t-PA NIHSS (stroke scale) EKG Noncontrast head CT Labs

    24. Initial work-up Time of onset Consider t-PA NIHSS (stroke scale) EKG Noncontrast head CT Labs

    25. Initial work-up Time of onset Consider t-PA NIHSS (stroke scale) EKG Noncontrast head CT Labs

    26. Initial work-up Time of onset Consider t-PA NIHSS (stroke scale) EKG Noncontrast head CT Labs Cr Coags PTT, INR, fibrinogen Hct Plts Glucose

    27. Case

    28. General management Permissive HTN Glucose < 150 using insulin Temperature < 37.8 Tylenol 650mg q 6hrs x 48hrs Fluids: euvolumia, isotonic saline, no glucose SaO2 > 92% Avoid Foley DVT prophylaxis Nutrition / swallowing

    29. General management Permissive HTN Glucose < 150 using insulin Temperature < 37.8 Tylenol 650mg q 6hrs x 48hrs Fluids: euvolumia, isotonic saline, no glucose SaO2 > 92% Avoid Foley DVT prophylaxis Nutrition / swallowing Stop or reduce HTN drugs Half B-blockers Consider cardiopulmonary needs Ischemic stroke BP < 210/120 BP < 180/105 if t-PA given Hemorrhagic stroke BP < 180/105 HTN treatment if needed 1st: Labetolol 10mg IV prn 2nd: Nicardipine gtt

    30. General management Permissive HTN Glucose < 150 using insulin Temperature < 37.8 Tylenol 650mg q 6hrs x 48hrs Fluids: euvolumia, isotonic saline, no glucose SaO2 > 92% Avoid Foley DVT prophylaxis Nutrition / swallowing Ischemic stroke SQ heparin 5000u tid +/- SCDs Hemorrhagic stroke SCDs All patients Early mobility

    31. Case

    32. Acute ASA CAST, IST trials* Small reduction of death or early recurrent ischemic stroke Abs risk reduction ~0.8% over placebo NNT ~125 Good outcome No or minimal disability at 6 months 10 per 1000 over placebo Bleeding risk 0.6% placebo 1.1% ASA

    33. Case

    34. Dont think heparin Multiple studies dont support acute heparin May cause hemorrhagic conversion Larger strokes have more risk Exceptions Recurrent thrombotic emboli Risk is only 5% in first 2 weeks for A-fib Impending carotid or basilar occlusion Cerebral venous thrombosis If heparin Goal PTT 50-80 Never bolus

    35. Question

    36. Whats acute

    37. END

More Related